Researchers in the United Kingdom have discovered that psilocybin, the psychedelic compound found in magic mushrooms, may provide long-lasting relief from chronic nerve pain and may even help standard pain medications work better.
The study, published in Communications Biology, suggests that psilocybin could eventually become part of a completely new approach to treating difficult chronic pain conditions.
Nerve pain is very different from ordinary pain.
It happens when nerves themselves become damaged or dysfunctional. This can occur after injuries, diabetes, viral infections, chemotherapy, surgery, or spinal problems.
People with nerve pain often describe burning sensations, electric shock-like pain, tingling, or severe sensitivity to touch. In many cases, the pain continues for months or years and seriously affects sleep, movement, mood, and quality of life.
Current treatments often fail to fully control the condition.
One widely used medication is gabapentin, which is commonly prescribed for chronic nerve pain. Although helpful for some patients, many people continue suffering even while taking the drug.
Researchers estimate that up to half of patients with neuropathic pain do not receive enough relief from gabapentin alone.
Doctors and scientists have therefore been searching for alternative treatments that work through different brain mechanisms.
In the new study, researchers at the University of Reading tested psilocybin in mice with nerve damage that caused chronic pain symptoms.
Psilocybin is best known as the psychoactive compound responsible for the hallucinogenic effects of magic mushrooms. In recent years, however, scientists have increasingly explored its possible medical uses.
Clinical research has already investigated psilocybin for depression, anxiety, addiction, and post-traumatic stress disorder.
The new research focused on whether psilocybin could also affect how the brain processes chronic pain.
The scientists found that a single dose of psilocybin produced significant pain relief in mice.
The effects began about two hours after injection and lasted for up to a month.
This long duration surprised researchers because the drug itself leaves the body much sooner.
The findings suggest that psilocybin may not simply block pain temporarily. Instead, it may change how the brain’s pain-processing networks function over time.
Researchers believe the drug may “reset” or reorganize neural circuits involved in chronic pain.
Perhaps the most striking finding involved gabapentin.
Several weeks after the single psilocybin dose, researchers gave gabapentin to the mice again.
Even though psilocybin’s own pain-relieving effect had already faded, gabapentin worked much better in mice previously exposed to psilocybin.
In those mice, gabapentin reduced pain for up to four days. In mice that had never received psilocybin, the drug’s effects were much weaker.
The researchers believe psilocybin may leave lasting changes in brain function that improve the effectiveness of other pain treatments.
Senior researcher Dr. Maria Maiarú said the findings are especially exciting because many people with chronic nerve pain have very limited treatment options.
She explained that current pain medications can cause serious side effects and, in some cases, addiction risks.
According to Dr. Maiarú, psilocybin may represent a fundamentally different type of treatment because it appears to reshape the brain systems involved in chronic pain itself.
The researchers also confirmed the effects in both male and female mice.
This matters because pain research has historically relied heavily on male animals, despite many chronic pain disorders being highly common in women.
The scientists followed U.K. animal welfare guidelines and minimized animal distress wherever possible.
Although the study results are promising, researchers caution that the work is still in an early stage.
The experiments were conducted only in mice, and much more research is needed before psilocybin could potentially be used for chronic pain treatment in humans.
Future studies will need to examine safety, dosing, long-term effects, and possible risks in people.
Researchers will also need to determine whether psilocybin can help different types of chronic pain beyond nerve damage.
The findings add to growing scientific interest in psychedelics and brain plasticity.
Brain plasticity refers to the brain’s ability to reorganize and form new connections. Scientists increasingly suspect that psychedelics may trigger long-lasting changes in brain networks, which could explain their prolonged effects on mood, behavior, and pain.
Study analysis and review:
This study is scientifically important because it explores a completely different way of treating chronic pain. Instead of only suppressing pain signals temporarily, psilocybin may change the brain systems responsible for maintaining chronic pain states.
One of the strongest findings was the interaction with gabapentin. The fact that psilocybin improved gabapentin’s effectiveness weeks later suggests long-lasting biological changes may occur in the brain.
Another major strength is the long duration of the pain relief after only one dose.
However, there are also important limitations. The study involved only mice, and psychedelic drugs can affect humans differently.
The research also does not yet explain exactly how psilocybin reorganizes pain-processing networks.
In addition, psychedelics can produce powerful psychological effects that may complicate medical use.
Despite these uncertainties, the findings open an exciting area of research into non-opioid pain treatments. If future human studies confirm the results, psilocybin-based therapies may eventually offer new hope for patients with severe chronic nerve pain who have exhausted current treatment options.
If you care about pain, please read studies about how to manage gout with a low-purine diet, and a guide to eating right for arthritis.
For more health information, please see recent studies about the link between processed foods and chronic diseases, and avoid these 8 foods to ease arthritis pain.
Source: University of Reading.
